LastChg. % 1DChg. Abs.
15.6000-3.11%-0.5000
Reference Price116.1000
Bid/Ask-/-
Bid Size/Ask Size-/-
Number Of Trades9
Last Volume2300
Total Value228,900

Performance data

Open14.5000
High15.7500
Low14.0000
Monthly Performance (MOM)+73.33%
Year-to-Date (YTD)-46.58%
52 Weeks Performance (YOY)-50.00%

Reference data & dividend

Marinomed Biotech AG is an Austrian, science-based biotech company with a growing development pipeline and globally marketed therapeutics. The Company develops innovative patent-protected products in the therapeutic areas immunology and virology based on the platform Marinosolv® and the virus-blocking activity of Carragelose®. The Marinosolv® technology improves the solubility and bioavailability of hardly soluble compounds and is used to develop new therapeutics for autoreactive immune disorders. The virology segment includes Carragelose®-based over-the-counter (OTC) products to prevent and treat respiratory viral infections that are partnered in more than 40 countries. The Company is headquartered in Korneuburg, Austria, and is listed on the prime market of the Vienna Stock Exchange (VSE:MARI). For further information, please visit: https://www.marinomed.com.

News

Trading parameters

Average prices & details

Generally, reference prices likewise correspond to prices from trades in a security.
  Exceptions:
  - Reference prices for securities that have been newly admitted to trading shall be determined by the
  exchange operating company.
  - Whenever the exchange operating company receives notice of corporate actions or distributions that
  may influence the price of a security, a reference price is determined for the ex-trading day adjusted
  for the theoretical value of the security.
  Further information on the reference price can be found in the
  Trading Rules for the Xetra® Trading System - § 5 Price Determination and Reference Price.
2 Double Counting
  Last Volume = number of traded securities of the last trade;
  Total Volume = sum of all traded securities of the last trading day
3 Calculated by Vienna Stock Exchange